MATERIALS AND METHODS
=====================

The study was carried on 1442 diabetic patients \[816 males and 626 females; age range 11 to 86 ([Table 1](#t1-kjim-2-1-42-6){ref-type="table"})\], and male to female ratio of 1.3:1 who were treated at the Chonnam University Hospital from 1982 to 1986.

Neuropathy was determined by clinical manifestations, Shellong test, and the changes in heart rate in response to forced respiration. Retinopathy was defined by fundoscopic examination and fluorescein retinal angiography. Furthermore, nephropathy, except patients with severe systemic disease or urinary tract infections, was determined by proteinuria and abnormal increase in serum BUN and creatinine levels. Infectious disease was confirmed on the basis of peripheral blood findings, radiological findings, as well as, bacteriological culture study. Cardiovascular complications were determined by clinical manifestations, physical findings, and diagnostic tests.

RESULTS
=======

The prevalence for the diabetic complication was 38.6% ([Table 1](#t1-kjim-2-1-42-6){ref-type="table"}) in all patient group age distribution of 31% for under 20 and 30%, 24%, 31%, 45% and 49% for 3rd, 4th, 5th, 6th and over 6th decade, respectively. There was a tendency of increasing incidence after 40 years of age.

Among the total complications, cardiovascular complication was most prevalent with incidence of 25.7% and others in the following order of neuropathy (24.2%), retinopathy (24.0%), nephropathy (15.5%), infection (10.5%) and acute diabetic coma (2.1%) ([Fig. 1](#f1-kjim-2-1-42-6){ref-type="fig"}).

There was no significant difference in prevalence of diabetic complications between male and female ([Table 1](#t1-kjim-2-1-42-6){ref-type="table"}).

In neuropathy, peripheral type was the most common complication and background retinopathy was frequently observed in diabetic retinopathy. Proliferative diabetic retinopathy was noted in 22 cases of 26 cases in patients over 40 years of age. Seventy percent of patients with nephropathy had proteinuria despite of normal BUN and creatinine levels, and the majority of patients were distributed in males over 40 years of age.

Hypertension was the most common cardiovascular complication in both genders, while atherosclerosis and cerebral thrombosis tended to be present in males over 40 years of age. Foot gangrene appeared in all age groups and most prevalent males in their sixties.

Among infectious diseases, pulmonary tuberculosis showed the highest frequency (21.6%) and skin infection (19.2%) and urinary tract infection (17.4%) were common, also emphysematous pyelonephritis was found in 2 cases.

The duration of diabetes for each major complications is shown in [Table 6](#t6-kjim-2-1-42-6){ref-type="table"}. Prevalence of diabetic complications increased parallely with the duration of the illness. The mean duration of diabetes for cardiovascular complication was 5.89 years and neuropathy with 5.96 years while retinopathy 7.14 years and nephropathy 7.9 years, which are rather longer than cardiovascular complication or neuropathy ([Fig. 3](#f3-kjim-2-1-42-6){ref-type="fig"}).

Occurrence of neuropathy in combination with retinopathy was the most common diabetic complication as evidenced by 121 cases of retinopathy in conjunction with nephropathy from a total of 291 cases. All three complications appearing in one patient, was noted in 54 cases.

DISCUSSION
==========

Diabetic neuropathy as well as macroangiopathy appeared at various clinical stages of diabetes mellitus^[@b1-kjim-2-1-42-6],[@b2-kjim-2-1-42-6]^, therefore, the prevalence may be varied depending on the criteria of diagnosis. In these authors' study, neuropathy (which was defined with definite clinical manifestations, positive Schellong test, and cardiac beat changes in response to deep respiration) was observed in 355 cases with prevalence of 24.6% which was somewhat higher from those in other Asian countries^[@b3-kjim-2-1-42-6]^.

It is well known that peripheral neuropathy is the most common form of diabetic neuropathy^[@b4-kjim-2-1-42-6]^ and this was confirmed in this study with prevalence of 83.4%. Prevalence of neuropathy reflected the duration of diabetes, i.e., under four years it was 17.5%, and for over 5 years-48.9%. These data showed an increase in prevalence according to duration of the illness as reported by others^[@b5-kjim-2-1-42-6],[@b6-kjim-2-1-42-6]^.

The incidence of retinopathy differed diagnosed either by direct ophthalmoscopic examinations of fluorescein retinal angiography^[@b7-kjim-2-1-42-6]^, and its tendency was to increase with age and with the duration of diabetes. In this study, based on a large number of diabetic patients who were initially free of complications, cumulative incidence of diabetic retinopathy was as 34.5% after 20 years later^[@b10-kjim-2-1-42-6]^. In this study, the prevalence of diabetic retinopathy was 22.5% and it was more frequently observed with increased duration of the illness, especially after 5 years and it had higher incidence as compared to these authors' previous study ([Fig. 4](#f4-kjim-2-1-42-6){ref-type="fig"}).

The mortality from diabetic nephropathy seems to increase recently and it is a problem to control terminal renal failure in diabetics. The overall prevalence rate of diabetic nephropathy was 15.5% in this study group, which was rather lower than that of Japan^[@b11-kjim-2-1-42-6]^, but higher than other reports^[@b12-kjim-2-1-42-6],[@b13-kjim-2-1-42-6]^, however, the incidence was higher than in these authors' study ([Fig. 1](#f1-kjim-2-1-42-6){ref-type="fig"}). Socioeconomic conditions and racial factors could be involved in such discrepancies^[@b14-kjim-2-1-42-6],[@b15-kjim-2-1-42-6]^. Similar to other reports^[@b16-kjim-2-1-42-6]--[@b18-kjim-2-1-42-6]^ the prevalence of diabetic nephropathy increased according to the duration of diabetes, old age group, and in male.

Cardiovascular diseases are well known as the most common complication and major causes of premature mortality in diabetics today^[@b19-kjim-2-1-42-6],[@b20-kjim-2-1-42-6]^. These results indicated that the prevalence of cardiovascular complications was 25.7% which was lower than those in Western countries^[@b21-kjim-2-1-42-6]^, Japan^[@b22-kjim-2-1-42-6]^ and Taiwan^[@b3-kjim-2-1-42-6]^ but similar to those in other Asian countries^[@b23-kjim-2-1-42-6]--[@b25-kjim-2-1-42-6]^. Since ischemic heart disease, including myocardial infarction, was not included in this study, the exact prevalence of cardiovascular disease and/or ischemic heart disease could be higher than this of this study. Prevalence of cardiovascular complications was increased according to the duration of diabetes, but was not related to sexes, which differs from other reports^[@b18-kjim-2-1-42-6],[@b26-kjim-2-1-42-6],[@b27-kjim-2-1-42-6]^.

The results suggest that chronic diabetic complications are related to the duration of disease and to the age of patients. Also, the prevalence rate of diabetic complications should be evaluated while considering other relevant factors, such as racial and socioeconomic status, and also, the possible risk factors for all complications.
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###### 

Diabetic Subjects and Prevalence of Complications

  Sex       Age (years)   Total                                                    
  --------- ------------- --------- ---------- ----------- ----------- ----------- -------------
  Male      19 (2)        30 (11)   96 (17)    251 (75)    260 (111)   160 (74)    816 (290)
  (35.5%)                                                                          
  Female    7 (6)         34 (8)    59 (20)    155 (51)    239 (113)   132 (69)    626 (267)
  (42.7%)                                                                          
                                                                                   
  Total     26 (8)        64 (19)   155 (37)   406 (126)   499 (224)   292 (143)   1,442 (557)
  (31%)     (30%)         (24%)     (31%)      (45%)       (49%)       (38.6%)     

Number in parentheses show prevalence of complications

###### 

Age and Sex Distributions of Diabetic Neuropathy

                          Sex   Age (years)   Total                                   
  ----------------------- ----- ------------- ------- ------- ------- ------- ------- ---------
  Peripheral neuropathy   M/F   1/2           4/4     11/10   38/36   74/68   28/30   156/140
  Autonomic neuropathy    M/F   0/1           1/0     1/0     3/3     4/5     6/4     15/13
  Combined neuropathy     M/F   0/0           1/1     0/1     4/2     8/6     6/2     19/12
                                                                                      
  Total                   M/F   1/3           6/5     12/11   35/41   86/69   40/36   190/165

M : Male,

F : Female

###### 

Age and Sex Distributions of Eye Complications

                                Sex   Age (years)   Total                                  
  ----------------------------- ----- ------------- ------- ------ ------- ------- ------- ---------
  Retinopathy                                                                              
    Background retinopathy      M/F   1/7           5/5     2/13   44/20   64/59   45/34   161/138
    Proliferative retinopathy   M/F   0/0           1/0     1/2    1/3     8/6     4/0     15/11
                                                                                           
    Total                       M/F   1/7           6/5     3/15   45/23   72/65   49/34   176/149
                                                                                           
  Cataract                      M/F   0/0           1/0     0/0    4/4     13/20   21/18   39/42

###### 

Age and Sex Distributions of Diabetic Nephropathy

                                                Sex   Age (years)   Total                                
  --------------------------------------------- ----- ------------- ------- ----- ------ ------- ------- -------
  Proteinuria                                   M/F   0/0           4/0     2/4   11/7   29/9    16/16   62/36
  Proteinuria with increased BUN & creatinine   M/F   0/1           0/0     2/0   3/2    4/4     17/5    26/12
                                                                                                         
  Total                                         M/F   0/1           4/0     4/4   14/9   33/13   33/21   88/48

###### 

Age and Sex Distributions of Diabetic Cardiovascular Complications

                        Sex   Age (years)   Total                                 
  --------------------- ----- ------------- ------- ----- ------- ------- ------- ---------
  Hypertension          M/F   0/0           3/0     2/8   17/20   33/54   25/30   80/92
  Atherosclerosis       M/F   0/0           0/0     0/0   5/0     7/1     0/2     12/3
  Cerebral thrombosis   M/F   0/0           0/0     0/1   3/1     7/3     2/1     12/3
  Gangrene              M/F   1/1           2/1     1/0   4/1     9/4     1/2     18/9
                                                                                  
  Total                 M/F   1/1           5/1     3/9   29/22   56/42   28/35   122/110

###### 

The Relation Between Prevalence of Complications and the Durations of Diabetes

                                 Duration of diabetes (years)                    
  ------------------------------ ------------------------------ ---------------- ----------------
  Neuropathy                     200/1,146 (17.5%)              75/186 (40.3%)   70/110 (63.6%)
  Retinopathy                    155/1,146 (13.5%)              57/186 (30.6%)   61/110 (55.5%)
  Nephropathy                    52/1,146 (4.5%)                33/186 (17.7%)   44/110 (40.0%)
  Cardiovascular Complications   121/1,146 (10.6%)              50/186 (26.9%)   55/110 (50.0%)
